New registry tracks Real-World safety of cholesterol drug lomitapide
Disease control
Completed
This observational registry followed 260 patients with homozygous familial hypercholesterolemia (a severe genetic condition causing very high cholesterol) who were taking lomitapide. The goal was to monitor long-term safety, especially liver problems and gastrointestinal issues, …
Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC